Holen Sie sich die Stockscreener-App
71.00
2.74%
-2.00
Handel nachbörslich:
71.00
Schlusskurs vom Vortag:
$73.00
Offen:
$73.16
24-Stunden-Volumen:
130.47K
Relative Volume:
2.50
Marktkapitalisierung:
$903.12M
Einnahmen:
$69.48M
Nettoeinkommen (Verlust:
$18.64M
KGV:
48.63
EPS:
1.46
Netto-Cashflow:
$13.01M
1W Leistung:
+0.97%
1M Leistung:
+23.33%
6M Leistung:
+28.15%
1J Leistung:
+61.44%
1-Tages-Spanne:
$70.82
$73.47
1-Wochen-Bereich:
$67.51
$73.47
52-Wochen-Spanne:
$43.17
$73.47
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Vergleichen Sie IRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
71.00 | 890.40M | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
Analyzing drawdowns of IRADIMED CORPORATION with statistical toolsWeekly Profit Report & Fast Moving Market Watchlists - Newser
Chart based exit strategy for IRADIMED CORPORATION2025 Bull vs Bear & Safe Swing Trade Setups - Newser
Is IRADIMED CORPORATION a candidate for recovery playHistorical Stock Summary and ROI Review - Newser
What’s the recovery path for long term holders of IRADIMED CORPORATIONGrowth Projection Summary for Long-Term Investors - Newser
Earnings visualization tools for IRADIMED CORPORATIONFree Alert Feed for Momentum Based Picks - Newser
Are Robust Financials Driving The Recent Rally In IRADIMED CORPORATION's (NASDAQ:IRMD) Stock? - Yahoo Finance
Risk adjusted return profile for IRADIMED CORPORATION analyzedInvestment Position Summary with Timeframe Forecast - Newser
Is IRADIMED CORPORATION stock poised for growthMarket Opportunity Tracker for Swing Traders - Newser
Will breakout in IRADIMED CORPORATION lead to full recoveryFree Trade Insight With Community Collaboration - Newser
What technical models suggest about IRADIMED CORPORATION’s comebackFree Weekly Growth Stock Entry Point Alerts - Newser
Analyzing IRADIMED CORPORATION with multi timeframe chartsFree Real Time Alerts Based on AI Prediction - Newser
Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛
Why IRADIMED CORPORATION stock attracts strong analyst attentionPredictable Return Plan with Entry Guidance - Newser
What MACD signals say about IRADIMED CORPORATIONDaily Stock Watch Summary with Key Insights - Newser
What makes IRADIMED CORPORATION stock price move sharplyLow Drawdown Picks with Weekly Updates - Newser
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stock Holdings in iRadimed Corporation (NASDAQ:IRMD) - Defense World
How IRADIMED CORPORATION stock performs during market volatilityFree AI-Powered Trade Planning with Indicators - Newser
Multi factor analysis applied to IRADIMED CORPORATIONSwing Trade Entry and Exit Point Analysis - Newser
Can IRADIMED CORPORATION Escape Recent Bear ChannelSmart Trade Plans With Risk Protection Explained - beatles.ru
Roth MKM Remains a Buy on Iradimed (IRMD) - The Globe and Mail
iRadimed (NASDAQ:IRMD) Trading 8.2% Higher After Dividend Announcement - Defense World
What Fibonacci levels say about IRADIMED CORPORATION reboundValue Investing Checklist with Entry Signals - Newser
Using data filters to optimize entry into IRADIMED CORPORATIONBuy Alert Based on RSI and Volume - Newser
iRadimed Corp (IRMD) Q2 2025 Earnings Call Highlights: Record Revenues and Strategic Product ... - uk.finance.yahoo.com
iRadimed Corp (IRMD) Q2 2025 Earnings Call Highlights: Record Revenues and Strategic Product ... By GuruFocus - Investing.com Canada
Why is IRADIMED CORPORATION stock attracting strong analyst attentionMaster stock selection with insider knowledge - Jammu Links News
What are the technical indicators suggesting about IRADIMED CORPORATIONDiscover market opportunities with real-time data - Jammu Links News
How strong is IRADIMED CORPORATION company’s balance sheetRapid profit acceleration - Jammu Links News
What are the latest earnings results for IRADIMED CORPORATIONDynamic investment opportunities - Jammu Links News
What is the dividend policy of IRADIMED CORPORATION stockAchieve rapid portfolio growth with smart picks - Jammu Links News
IRADIMED CORPORATION stock trend outlook and recovery pathTrend Reversal Probability Forecast Update - Newser
iRadimed (NASDAQ:IRMD) Hits New 52-Week High Following Dividend Announcement - Defense World
IRadimed Corporation (NASDAQ:IRMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Trend Reversal Possible in IRADIMED CORPORATION Charts IndicateGrowth Based Stock Signal Screener Updated - beatles.ru
iRadimed (NASDAQ:IRMD) Shares Gap Up Following Dividend Announcement - Defense World
Iradimed Corp Reports Record Q2 2025 Results - TipRanks
How hedge fund analytics apply to IRADIMED CORPORATION stockFree Trade Setups With Clear Risk Limits - Newser
Iradimed Corp’s Earnings Call Highlights Record Growth - TipRanks
IRADIMED CORP SEC 10-Q Report - TradingView
IRadimed: Q2 Earnings Snapshot - The Washington Post
Earnings call transcript: Iradimed Co beats Q2 2025 forecasts, stock surges - Investing.com Canada
Earnings call transcript: Iradimed Co beats Q2 2025 forecasts, stock surges By Investing.com - Investing.com South Africa
Iradimed Outpaces Expectations With Strong Earnings And Forecasts - Finimize
iRadimed (IRMD) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Iradimed Co earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
Iradimed Corp Q2 Profit Climbs - Nasdaq
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):